S

Silfurberg

Europe, Gullbringusysla, Iceland, Reykjavík

Description

Silfurberg is an international venture capital firm that invests in early-stage health care, biotech, and other life science companies.

Investor Profile

Silfurberg has made 3 investments, with 0 in the past 12 months and 33% as lead.

Stage Focus

  • Series C (33%)
  • Series B (33%)
  • Series A (33%)

Country Focus

  • Iceland (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Silfurberg frequently co-invest with?

Novartis Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 2
Innovation and Technology Venture Fund
Asia, Hong Kong Island, Hong Kong, Wan Chai
Co-Investments: 1
Earlybird Venture Capital
Europe, Berlin, Germany, Berlin
Co-Investments: 1
BVCF
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Nan Fung Life Sciences
North America, California, United States, San Francisco
Co-Investments: 1
Bay City Capital
North America, California, United States, San Francisco
Co-Investments: 2
Tekla Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 1
Brunnur Ventures
Europe, Gullbringusysla, Iceland, Reykjavík
Co-Investments: 3
Pivotal bioVenture Partners
North America, California, United States, San Francisco
Co-Investments: 2
Hyfinity Investments
Asia, Beijing, China, Beijing
Co-Investments: 1

What are some of recent deals done by Silfurberg?

Oculis

Reykjavík, Gullbringusysla, Iceland

Oculis is a clinical-stage biopharmaceutical development company focusing on ophthalmic drugs and novel drug delivery.

BiotechnologyHealth CarePharmaceutical
Series CMay 4, 2021
Amount Raised: $57,000,000
Oculis

Reykjavík, Gullbringusysla, Iceland

Oculis is a clinical-stage biopharmaceutical development company focusing on ophthalmic drugs and novel drug delivery.

BiotechnologyHealth CarePharmaceutical
Series BJan 4, 2018
Amount Raised: $20,523,598
Oculis

Reykjavík, Gullbringusysla, Iceland

Oculis is a clinical-stage biopharmaceutical development company focusing on ophthalmic drugs and novel drug delivery.

BiotechnologyHealth CarePharmaceutical
Series AAug 16, 2016